Cardica Resumes MicroCutter Clinical Study In Europe

Cardica, Inc. CRDC today announced that the first patients have been successfully treated without complications in the European clinical study of its MicroCutter cutting/stapling device. The trial is designed to evaluate the use of the MicroCutter device in a variety of gastrointestinal surgical procedures including transections, resections and anastomoses. To date, approximately 30 surgeons in six European facilities have successfully used the MicroCutter XCHANGE™ 30 device, a cartridge-based cutter/stapler with a five millimeter shaft diameter, for more than 230 deployments in more than 80 procedures. These patients were treated prior to the resumption of the trial.